Your browser doesn't support javascript.
loading
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
Hiller, Aimee; Biedermann, Luc; Fournier, Nicolas; Butter, Matthias; Vavricka, Stephan R; Ciurea, Adrian; Rogler, Gerhard; Scharl, Michael.
Afiliação
  • Hiller A; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Biedermann L; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Fournier N; Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland.
  • Butter M; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Vavricka SR; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Ciurea A; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Rogler G; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Scharl M; Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
PLoS One ; 14(4): e0211554, 2019.
Article em En | MEDLINE | ID: mdl-31039159
ABSTRACT
BACKGROUND/

AIMS:

Extraintestinal manifestations (EIM) involving joints, skin, eyes and liver represent an important problem in the treatment of IBD patients. The aim of this study was to identify factors that are associated with the occurrence of joint EIM and therefore allow an early diagnosis and guide medical treatment.

METHODS:

We studied clinical and epidemiological data from 3298 patients included in the Swiss IBD Cohort Study (SIBDCS), 1860 suffered from Crohn's disease (CD) and 1438 from ulcerative colitis or IBD unclassified (UC/IBDU).

RESULTS:

We found female gender as well as a longer disease duration and activity (specified as CDAI or MTWAI, respectively) to be related to the appearance of arthritis/arthralgia, but also sacroiliitis/ankylosing spondylitis in IBD patients. IBD patients with arthritis/arthralgia or sacroiliitis/ankylosing spondylitis were more often treated with anti-TNF and patients with arthritis/arthralgia underwent more often IBD-related surgeries. We revealed that eye or skin EIM were more frequent in patients with arthritis/arthralgia or sacroiliitis/ankylosing spondylitis. In multivariate analysis, we confirmed female gender, longer disease duration, IBD-related surgery, presence of other EIM and treatment with anti-TNF to be independent risk factors for the onset of arthritis/arthralgia in CD and UC/IBDU patients.

CONCLUSION:

In this study, we demonstrated that markers for a more severe disease course were associated with the onset of joint EIM in IBD patients. Our data suggest that in particular females under anti-TNF treatment and patients suffering from non-joint and/or IBD-related surgery should be close and carefully monitored for presence of arthritis or sacroiliitis/ankylosing spondylitis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite / Espondilite Anquilosante / Colite Ulcerativa / Doença de Crohn Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite / Espondilite Anquilosante / Colite Ulcerativa / Doença de Crohn Idioma: En Ano de publicação: 2019 Tipo de documento: Article